Phenylbiguanide

Chemical compound
  • UN: Unscheduled
Identifiers
  • 1-Phenylbiguanide
CAS Number
  • 102-02-3
PubChem CID
  • 4780
ChemSpider
  • 4616
UNII
  • W8PKA3T2I3
ChEBI
  • CHEBI:75377
ChEMBL
  • ChEMBL13791
CompTox Dashboard (EPA)
  • DTXSID90144508 Edit this at Wikidata
ECHA InfoCard100.002.726 Edit this at WikidataChemical and physical dataFormulaC8H11N5Molar mass177.211 g·mol−13D model (JSmol)
  • Interactive image
Melting point135–142 °C (275–288 °F)
  • c1ccc(cc1)NC(=N)NC(=N)N
InChI
  • InChI=1S/C8H11N5/c9-7(10)13-8(11)12-6-4-2-1-3-5-6/h1-5H,(H6,9,10,11,12,13)
  • Key:CUQCMXFWIMOWRP-UHFFFAOYSA-N

Phenylbiguanide (PBG) is a 5-HT3 agonist used to study the role of 5-HT3 receptors in the central nervous system.[1] It has been found to trigger dopamine release in the nucleus accumbens of rats.[2]

Derivatives

  • Phenylbiguanide is used to make amanozine and benfosformin.[citation needed]

References

  1. ^ Higgins GA, Joharchi N, Sellers EM (March 1993). "Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats". The Journal of Pharmacology and Experimental Therapeutics. 264 (3). Journal of Pharmacology and Experimental Therapeutics: 1440–9. PMID 8450478.
  2. ^ Chen JP, van Praag HM, Gardner EL (March 1991). "Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens". Brain Research. 543 (2). Brain Research.: 354–7. doi:10.1016/0006-8993(91)90050-6. PMID 1711914. S2CID 37426395.
  • v
  • t
  • e
Serotonin receptor modulators
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e